Expansion of CD5+ B-cell overexpressing CD81 in HCV infection: Towards better understanding the link between HCV infection, B-cell activation and lymphoproliferation

Journal of Hepatology

Volumn 38, Issue 5, 2003, Pages 674-676

  Zuckerman, Eli ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIVIRUS AGENT; AUTOANTIBODY; CD19 ANTIGEN; CD5 ANTIGEN; CD81 ANTIGEN; CELL SURFACE PROTEIN; COMPLEMENT COMPONENT C3D RECEPTOR; CRYOGLOBULIN; IMMUNOGLOBULIN IDIOTYPE; IMMUNOGLOBULIN M; INTERLEUKIN 10; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN E2; RHEUMATOID FACTOR; TETRASPANIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RECEPTOR; VIRUS RNA;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B CELL LYMPHOMA; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CHRONIC HEPATITIS; CLINICAL FEATURE; CLONAL VARIATION; CORRELATION ANALYSIS; CRYOGLOBULINEMIA; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EDITORIAL; EPSTEIN BARR VIRUS; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC TRANSFORMATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGLOBULIN GENE; IMMUNOMODULATION; LIVER CELL; LYMPH FOLLICLE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT TRANSFORMATION; MONONUCLEAR CELL; NONHODGKIN LYMPHOMA; ONTOGENY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; SOMATIC MUTATION; UPREGULATION; VIREMIA; VIRION; VIRUS GENOME; VIRUS LOAD; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 0038216600     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00122-3     Document Type: Editorial

References (39)

1. Hoofnagle JH, Tralka TS. Introduction: the National Institutes of Health Consensus Development Conference: management of hepatitis C virus. Hepatology 1997;26(Suppl 1):1S-2S.
2. National Institutes of Health Consensus Development Conference Panel statement. Management of hepatitis C virus. Hepatology 1997;26(Suppl 1):2S-10S.
3. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatology 1992;15:382-386.
4. Zignego AL, De Carli M, Monti M, Careccia G, La Villa G, Giannini C, et al. Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. J Med Virol 1995;47:58-64.
5. Shimizu YK, Igarashi H, Kanematu T, Fujiwara K, Wong DC, Purcell RH, et al. Sequence analysis of hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees. J Virol 1997;71:5769-5773.
6. Moldvay J, Deny P, Pol S, Brechot C, Lamas E. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization. Blood 1994;83:269-273.
7. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, et al. Hepatitis C infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992;117:573-577.
8. Angello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-1495.
9. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet C, Pateron D, et al. Lymphocytic sialadenitis of Sjörgen's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-323.
10. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, Andre C, et al. Extrahepatic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995;122:169-173.
11. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Ann Intern Med 1995;123:615-620.
12. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995;21:613-619.
13. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-394.
14. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996;87:4296-4301.
15. Zuckerman E, Rosenvald-Zuckerman T, Duer D, Levine A, Fong TL. Hepatitis C infection in patients with non-Hodgkin B-cell lymphoma. Ann Intern Med 1997;127:423-428.
16. Zehender G, Meroni L, De Maddalena C, Varchetta S, Monti G, Galli M. Detection of hepatitis C virus RNA in CD19 peripheral mononuclear cells of chronically infected patients. J Infect Dis 1997;176:1209-1214.
17. L kv325 immunoglobulin gene combination in hepatitis C virus associated immunocytomas. Blood 1998;91:2433-2442.
18. Sasso EH. The rheumatoid factor response in the etiology of mixed cryoglobulinemia associated with hepatitis C virus infection. Ann Med Interne (Paris) 2000;15(1):30-40.
19. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al. Binding of hepatitis C virus to CD81. Science 1998;282:938-941.
20. Levy S, Todd SC, Maecker HT. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 1998;16:89-106.
21. Monteverde A, Ballare M, Pileri S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol 1997;19:99-110.
22. + B cell. Adv Immunol 1989;47:117-185.
23. + B cells. Science 1987;236:81-83.
24. Plater Zybrec C, Maini RN, Lam K, Kennedy TD, Janossy G. A rheumatoid arthritis B cell subset express a phenotype similar to that in chronic lymphocytic leukemia. Arthritis Rheum 1985;28:971-976.
25. Dauphinee M, Tovar Z, Talal N. B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis Rheum 1988;31:642-647.
26. + B cells in patients with infectious mononucleosis. Br J Haematol 1990;74:375-376.
27. + B lymphocytes in HIV infection: relationship to immunological progression of disease. Clin Immunol Immunopathol 1993;66:260-268.
28. Pietrogrande M, Corona M, Milani S, Rosti A, Ramella M, Tordato G. Relationship between rheumatoid factor and the immune response against hepatitis C virus in essential mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13(Suppl 13):109-113.
29. + B cells is associated with mild disease in chronic hepatitis C virus infection. J Hepatol 2000;32:121-125.
30. Zuckerman E, Slobodin G, Kessel A, Sabo E, Yeshurun D, Halas K, et al. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin Exp Immunol 2002;128:353-358.
31. pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J Hepatol 2003;38:642-650.
32. Kronenberger B, Roster B, Elez R, Weber S, Piiper A, Lee J-H, et al. Interferon alfa down-regulates CD81 in patients with chronic hepatitis C. Hepatology 2001;33:1518-1526.
33. Miyazaki T, Muller U, Campbell KS. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81. EMBO J 1997;16:4217-4225.
34. Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998;160:3594-3601.
35. Fornasieri A, Bernasconi P, Ribero ML, Sinico RA, Fasola M, Zhou L, et al. Hepatitis C virus (HCV) in lymphocyte subset and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinemia. Clin Exp Immunol 2000;122:400-403.
36. Franzin F, Efremov DG, Pozzato G, Tulissi P, Batista F, Burrone OR. Clonal B-cell expansion in peripheral blood of HCV-infected patients. Br J Haematol 1995;90:548-552.
37. Zuckerman E, Zuckerman T, Sahar D, Streichman S, Yeshurun D, Rowe JM. Bcl-2 and immunoglobulin gene rearrangement in patients with HCV infection. Br J Haematol 2001;112:364-369.
38. Zignego AL, Giannelli F, Marrocchi ME, et al. T(14:18) translocation in chronic hepatitis C virus infection. Hepatology 2000;31:474-479.
39. Gary-Gouy H, Harriague J, Bismuth G, Platzer C, Schmitt C, Dalloul AH. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 2002;100:4537-4543.